Home ⟩ Insights

Insights

management

3 min read • May 27, 2025

Organigram CEO To Retire After Building Canada’s Largest Cannabis Brand: Here’s What’s Next

2 min read • March 12, 2025

Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will ‘Strategically Deploy Capital To Create Growth’ In 2025

3 min read • December 8, 2024

Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip

3 min read • December 6, 2024

Ka-Ching! Schwazze’s Cannabis Accounting Bloopers And Other Historic Missteps That Shook Up Big Business

3 min read • December 4, 2024

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

6 min read • December 2, 2024

Beyond The CBD Bubble: Can Hemp Fiber Boost US Manufacturing With Eco-Friendly Products?

4 min read • November 28, 2024

The Mold-Killing Machine For Weed That Would Survive The New Shark Tank Season

3 min read • November 27, 2024

The Hidden Cost Of Legal Weed: Why Marijuana Taxes Are Hitting Your Wallet Harder Than You Think

5 min read • November 14, 2024

Can Pre-Roll Humidors Save Your Cannabis Brand? Custom Cones USA Says Yes

2 min read • October 31, 2024

Edibles Surge In The Heartland: MariMed’s Play For Missouri And Illinois Cannabis Dominance

2 min read • October 24, 2024

170 Banks Now Armed With Data Insights: Green Check Rolls Out Cannabis Banking Solutions

4 min read • October 23, 2024

EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won’t Change A Billion-Dollar Play

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)